DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
PNTG logo

The Pennant Group, Inc. Stock Price

NasdaqGS:PNTG Community·US$1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PNTG Share Price Performance

US$39.20
13.62 (53.24%)
​
US$46.33
Fair Value
US$39.20
13.62 (53.24%)
15.4% undervalued intrinsic discount
US$46.33
Fair Value
Price US$39.20
AnalystConsensusTarget US$46.33
AnalystLowTarget US$44.00
AnalystHighTarget US$49.00
Fri, 14 Aug 26
Fair ValueUS$46.33
Share Pricen/a

PNTG Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$46.33 15.4% undervalued intrinsic discount

Aging US Demographics Will Expand Home Health Services

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$44 10.9% undervalued intrinsic discount

Medicare Cuts, Workforce Strain Will Test Operations But Spark Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$49 20.0% undervalued intrinsic discount

Aging Population And Home Care Will Expand Market Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
PNTG logo
Pennant Group
15.4% undervalued intrinsic discount

Aging US Demographics Will Expand Home Health Services

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 14 Aug
Read Narrative
PNTG logo
Pennant Group
10.9% undervalued intrinsic discount

Medicare Cuts, Workforce Strain Will Test Operations But Spark Resilience

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
PNTG logo
Pennant Group
20.0% undervalued intrinsic discount

Aging Population And Home Care Will Expand Market Access

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 30 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
PNTG logo

PNTG: Home Health Margin Momentum Will Drive Future Stock Upside

Fair Value: US$44 10.9% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
PNTG logo

PNTG: Home Health And Hospice Expansion Plus AI Investments Are Expected To Support Upside

Fair Value: US$46.33 15.4% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
PNTG logo

PNTG: Sector Demand Tailwinds And Index Inclusion Will Support Future Upside

Fair Value: US$49 20.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Moderate growth potential with mediocre balance sheet.

1 Risk
3 Rewards
View Full Analysis

The Pennant Group, Inc. Key Details

US$1.1b

Revenue

US$885.9m

Cost of Revenue

US$215.8m

Gross Profit

US$183.5m

Other Expenses

US$32.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.93
19.59%
2.93%
48.8%
View Full Analysis

About PNTG

Founded
2019
Employees
9700
CEO
Brent Guerisoli
WebsiteView website
pennantgroup.com

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.

Recent PNTG News & Updates

User avatar
Narrative Update • Sep 03

PNTG: Home Health Margin Momentum Will Drive Future Stock Upside

The Pennant Group analyst fair value estimate has been raised from $40.00 to $44.00, as analysts point to stronger Q2 results, higher full year guidance, improving home health and hospice margins, and a more stable reimbursement backdrop as key supports for the higher targets. Analyst Commentary on Pennant Group Recent Street research on Pennant Group centers on stronger Q2 performance, updated full year guidance and the outlook for margins in home health and hospice.
User avatar
Narrative Update • Aug 14

PNTG: Home Health And Hospice Expansion Plus AI Investments Are Expected To Support Upside

Pennant Group’s updated analyst price target has moved higher by about $2.83 to roughly $46.33, with analysts pointing to stronger Q2 performance, improving home health and hospice margins, and sector demand trends as key supports for the change. Analyst Commentary Recent research on Pennant Group focuses on how Q2 execution, margin trends, and sector demand expectations feed into updated valuation views.

Recent updates

No updates

The Pennant Group, Inc. Competitors

HQY logo

HealthEquity

Symbol: NasdaqGS:HQY
Market cap: US$7.8b
HNGE logo

Hinge Health

Symbol: NYSE:HNGE
Market cap: US$7.1b
PACS logo

PACS Group

Symbol: NYSE:PACS
Market cap: US$7.1b
CHE logo

Chemed

Symbol: NYSE:CHE
Market cap: US$6.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide